Hypoxia reduces the inhibitory effect of IL-1β on chondrogenic differentiation of FCS-free expanded MSC

Ganey, 2002, A potential role for cell-based therapeutics in the treatment of intervertebral disc herniation, Eur Spine J, 11, 206, 10.1007/s00586-002-0494-7 Urban, 2003, Degeneration of the intervertebral disc, Arthritis Res Ther, 5, 120, 10.1186/ar629 Maroudas, 1975, Factors involved in the nutrition of the human lumbar intervertebral disc: cellularity and diffusion of glucose in vitro, J Anat, 120, 113 Buckwalter, 1995, Aging and degeneration of the human intervertebral disc, Spine, 20, 1307, 10.1097/00007632-199506000-00022 Kraemer, 1995, Natural course and prognosis of intervertebral disc diseases. International Society for the Study of the Lumbar Spine Seattle, Washington, June 1994, Spine, 20, 635, 10.1097/00007632-199503150-00001 Colombini, 2008, Pathophysiology of the human intervertebral disc, Int J Biochem Cell Biol, 40, 837, 10.1016/j.biocel.2007.12.011 Sakai, 2005, Differentiation of mesenchymal stem cells transplanted to a rabbit degenerative disc model: potential and limitations for stem cell therapy in disc regeneration, Spine, 30, 2379, 10.1097/01.brs.0000184365.28481.e3 Nishimura, 1998, Percutaneous reinsertion of the nucleus pulposus. An experimental study, Spine, 23, 1531, 10.1097/00007632-199807150-00006 Okuma, 2000, Reinsertion of stimulated nucleus pulposus cells retards intervertebral disc degeneration: an in vitro and in vivo experimental study, J Orthop Res, 18, 988, 10.1002/jor.1100180620 Kluba, 2005, Human anulus fibrosis and nucleus pulposus cells of the intervertebral disc: effect of degeneration and culture system on cell phenotype, Spine, 30, 2743, 10.1097/01.brs.0000192204.89160.6d Raghunath, 2005, Advancing cartilage tissue engineering: the application of stem cell technology, Curr Opin Biotechnol, 16, 503, 10.1016/j.copbio.2005.08.004 Steck, 2005, Induction of intervertebral disc-like cells from adult mesenchymal stem cells, Stem Cells, 23, 403, 10.1634/stemcells.2004-0107 Richardson, 2006, Intervertebral disc cell-mediated mesenchymal stem cell differentiation, Stem Cells, 24, 707, 10.1634/stemcells.2005-0205 Bartels, 1998, Oxygen and lactate concentrations measured in vivo in the intervertebral discs of patients with scoliosis and back pain, Spine, 23, 1, 10.1097/00007632-199801010-00001 Bibby, 2004, Effect of nutrient deprivation on the viability of intervertebral disc cells, Eur Spine J, 13, 695, 10.1007/s00586-003-0616-x Ishihara, 1999, Effects of low oxygen concentrations and metabolic inhibitors on proteoglycan and protein synthesis rates in the intervertebral disc, J Orthop Res, 17, 829, 10.1002/jor.1100170607 Urban, 2004, Nutrition of the intervertebral disc, Spine, 29, 2700, 10.1097/01.brs.0000146499.97948.52 Le Maitre, 2004, Localization of degradative enzymes and their inhibitors in the degenerate human intervertebral disc, J Pathol, 204, 47, 10.1002/path.1608 Majumdar, 2001, BMP-2 and BMP-9 promotes chondrogenic differentiation of human multipotential mesenchymal cells and overcomes the inhibitory effect of IL-1, J Cell Physiol, 189, 275, 10.1002/jcp.10025 Mohamed-Ali, 1995, Influence of interleukin-1 beta, tumour necrosis factor alpha and prostaglandin E2 on chondrogenesis and cartilage matrix breakdown in vitro, Rheumatol Int, 14, 191, 10.1007/BF00262297 Egli, 2008, Hypoxic expansion promotes the chondrogenic potential of articular chondrocytes, J Orthop Res, 13, 1159 Kanichai, 2008, Hypoxia promotes chondrogenesis in rat mesenchymal stem cells: a role for AKT and hypoxia-inducible factor (HIF)-1alpha, J Cell Physiol, 10.1002/jcp.21446 Khan, 2007, Hypoxic conditions increase hypoxia-inducible transcription factor 2alpha and enhance chondrogenesis in stem cells from the infrapatellar fat pad of osteoarthritis patients, Arthritis Res Ther, 9, R55, 10.1186/ar2211 Malladi, 2007, Hypoxia inducible factor-1alpha deficiency affects chondrogenesis of adipose-derived adult stromal cells, Tissue Eng, 13, 1159, 10.1089/ten.2006.0265 1997, Medicinal and other products and human and animal transmissible spongiform encephalopathies: memorandum from a WHO meeting, Bull World Health Organ, 75, 505 MacDermott, 1983, Fetal calf serum augmentation during cell separation procedures accounts for the majority of human autologous mixed leukocyte reactivity, Behring Inst Mitt, 122 Kievits, 1988, H-2-dependent binding of xenogeneic beta 2-microglobulin from culture media, J Immunol, 140, 4253, 10.4049/jimmunol.140.12.4253 Skottman, 2006, The derivation of clinical-grade human embryonic stem cell lines, FEBS Lett, 580, 2875, 10.1016/j.febslet.2006.03.083 Muller, 2006, Animal serum-free culture conditions for isolation and expansion of multipotent mesenchymal stromal cells from human BM, Cytotherapy, 8, 437, 10.1080/14653240600920782 Yamamoto, 2003, Effects of autologous serum on osteoblastic differentiation in human bone marrow cells, J Med Dent Sci, 50, 63 Dominici, 2006, Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement, Cytotherapy, 8, 315, 10.1080/14653240600855905 Böck P. Romeis Mikroskopische Technik, 1989. Tscheudschilsuren, 2006, Regulation of mesenchymal stem cell and chondrocyte differentiation by MIA, Exp Cell Res, 312, 63 Lucarelli, 2003, Platelet-derived growth factors enhance proliferation of human stromal stem cells, Biomaterials, 24, 3095, 10.1016/S0142-9612(03)00114-5 Banfi, 2000, Proliferation kinetics and differentiation potential of ex vivo expanded human bone marrow stromal cells: implications for their use in cell therapy, Exp Hematol, 28, 707, 10.1016/S0301-472X(00)00160-0 van den Berg, 1999, Pathogenesis of joint damage in rheumatoid arthritis: evidence of a dominant role for interleukin-I, Baillieres Best Pract Res Clin Rheumatol, 13, 577, 10.1053/berh.1999.0047 Dinarello, 2004, Therapeutic strategies to reduce IL-1 activity in treating local and systemic inflammation, Curr Opin Pharmacol, 4, 378, 10.1016/j.coph.2004.03.010 Alten, 2008, The human anti-IL-1 beta monoclonal antibody ACZ885 is effective in joint inflammation models in mice and in a proof-of-concept study in patients with rheumatoid arthritis, Arthritis Res Ther, 10, R67, 10.1186/ar2438 Risbud, 2004, Differentiation of mesenchymal stem cells towards a nucleus pulposus-like phenotype in vitro: implications for cell-based transplantation therapy, Spine, 29, 2627, 10.1097/01.brs.0000146462.92171.7f Koay, 2008, Hypoxic chondrogenic differentiation of human embryonic stem cells enhances cartilage protein synthesis and biomechanical functionality, Osteoarthritis Cartilage, 16, 1450, 10.1016/j.joca.2008.04.007 Gelse, 2008, Chondrogenic differentiation of growth factor-stimulated precursor cells in cartilage repair tissue is associated with increased HIF-1alpha activity, Osteoarthritis Cartilage, 16, 1457, 10.1016/j.joca.2008.04.006 Mueller, 2008, Functional characterization of hypertrophy in chondrogenesis of human mesenchymal stem cells, Arthritis Rheum, 58, 1377, 10.1002/art.23370 Pelttari, 2008, The use of mesenchymal stem cells for chondrogenesis, Injury, 39, 58, 10.1016/j.injury.2008.01.038 Zimmermann, 2008, Correlation of COL10A1 induction during chondrogenesis of mesenchymal stem cells with demethylation of two CpG sites in the COL10A1 promoter, Arthritis Rheum, 58, 2743, 10.1002/art.23736 Mwale, 2006, Suppression of genes related to hypertrophy and osteogenesis in committed human mesenchymal stem cells cultured on novel nitrogen-rich plasma polymer coatings, Tissue Eng, 12, 2639, 10.1089/ten.2006.12.2639 Kavalkovich, 2002, Chondrogenic differentiation of human mesenchymal stem cells within an alginate layer culture system, In Vitro Cell Dev Biol Anim, 38, 457, 10.1290/1071-2690(2002)038<0457:CDOHMS>2.0.CO;2 Steinert, 2003, Chondrogenic differentiation of mesenchymal progenitor cells encapsulated in ultrahigh-viscosity alginate, J Orthop Res, 21, 1090, 10.1016/S0736-0266(03)00100-1 Cho, 2004, Chondrogenic differentiation of human mesenchymal stem cells using a thermosensitive poly(N-isopropylacrylamide) and water-soluble chitosan copolymer, Biomaterials, 25, 5743, 10.1016/j.biomaterials.2004.01.051